Blog

In response to the COVID-19 pandemic, the Centers for Medicare and Medicaid Services (CMS), the U.S. Surgeon General and many medical specialties recommended interim cancelation…

With a continued reduction in COVID-19 cases, one health system was busy mapping out next steps to resuming elective surgeries and procedures At its high…

Distributors are working tirelessly to ensure product gets to providers. The warning bells began to go off in January. Back in January when COVID-19 started…

Resourceful and tenacious Challenges abound, but so do solutions, amid the COVID-19 pandemic Editor’s note: In the following interview, Ed Hardin, vice president, supply chain,…

AstraZeneca has received more than $1 billion from BARDA to develop a coronavirus vaccine from Oxford University. The drugmaker has agreed to initially supply at…

Global cases of the novel coronavirus surpassed 5 million this week, nearly five months after the first infection was reported in Wuhan, China. The virus…

A University of Pennsylvania Wharton model forecasts 4.3 million infected in the U.S. by the third week of July if states reopen while still practicing…

The Biomedical Advanced Research and Development Authority (BARDA) has awarded a $354 million, four-year contract to Phlow Corp. (Richmond, VA), a new company, to manufacture…

Moderna’s (Massachusetts) coronavirus vaccine produced COVID-19 antibodies in all 45 participants in an early-stage human trial. Each participant received a 25, 100 or 250 microgram…

Researchers from the NIH and the University of Oxford have a produced a vaccine that appears to protect animals from developing pneumonia or an immune-enhanced…